Enochian Biosciences Inc ENOB Balance Sheet

Enochian biosciences inc (ENOB)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Mar'11
ASSETS
Current Assets:
Cash
10,939	8,626	11,138	12,282	10,272	13,240	13,405	15,600	17,018	2,306	2,944	3,941	33	117	31	23	151	531	1,048	421	3,434	3,008	-	181	54	18	-	-	-	4	-	-	-	-	-	-
Cash (1)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	597	-	-	-	0	0	6	-	2	0	0	0	12	0
Cash held in escrow
-	-	-	-	-	-	-	-	-	4,811	-	-	-	-	-	-	0	0	0	1,052	0	2,029	1,708	147	423	77	-	-	-	0	-	-	-	-	-	-
Other receivables
-	2	14	20	1	3	0	122	31	104	181	223	194	154	746	695	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	643	581	460	432	41	8	35	85	69	25	-	-	-	81	-	-	-	-	-	-
Prepaid expenses
326	433	56	191	232	25	142	38	15	15	35	33	6	9	6	13	39	79	59	0	-	0	3	9	11	19	-	-	-	19	-	-	-	-	-	-
Loans receivable - related parties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13	13	13	-	13	13	13	13	8	0
Total Current Assets
11,265	9,063	11,209	12,494	10,506	13,268	13,547	15,762	17,065	7,237	3,161	4,198	234	281	784	732	835	1,192	1,568	1,906	3,476	5,046	2,345	422	559	141	13	13	19	105	15	13	13	13	20	0
Property and Equipment
-	-	-	-	-	-	-	-	275	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation
-	-	-	-	-	-	-	-	246	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property and equipment, net
793	776	734	687	743	654	334	27	28	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	40	0	-	-	-	2	-	-	-	-	-	-
OTHER ASSETS
Definite life intangible assets, net
79	84	89	93	146,277	148,255	150,137	111	127,137	122	124	124	120	121	132	135	142	140	160	164	161	186	199	220	233	231	-	-	-	239	-	-	-	-	-	-
Indefinite life intangible assets
154,824	154,824	154,824	154,824	-	-	-	154,824	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill
11,640	11,640	11,640	11,640	11,640	11,640	11,640	11,640	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deposits and other assets
137	137	137	137	138	137	137	137	32	8	2	2	2	2	2	2	2	2	2	2	6	7	7	8	10	10	-	-	-	14	-	-	-	-	-	-
Right of use assets
1,769	1,833	1,985	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Stock Offering Cost
-	-	-	-	-	-	-	-	-	10	-	-	25	25	25	-	-	-	-	-	-	0	0	67	67	67	-	-	-	0	-	-	-	-	-	-
Loan Receivable
-	-	-	-	-	-	-	-	0	446	422	196	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Other Assets
168,450	168,519	168,676	166,694	158,055	160,033	161,915	166,713	127,170	589	549	323	147	149	160	138	145	142	162	166	167	193	206	295	311	308	-	-	-	254	-	-	-	-	-	-
TOTAL ASSETS
180,509	178,359	180,619	179,877	169,305	173,956	175,797	182,502	144,264	7,827	3,711	4,522	382	430	944	870	980	1,335	1,731	2,072	3,643	5,239	2,551	718	911	450	13	13	19	362	15	13	13	13	20	0
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Advances for the Purchase of Common Stock
-	-	-	-	-	-	-	-	0	4,811	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable and accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	3	7	-	-	-	0	-	-	-
Advances from affiliate
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
Loan payable - related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	38	38	38	-	38	33	22	17	13	8
Notes Payable - Related Party, current portion
-	-	-	-	-	-	-	-	0	89	88	1,688	104	103	103	102	102	101	101	100	99	99	1,610	1,716	1,705	728	35	26	25	106	9	5	5	5	5	0
Stock Subscription Held in Escrow
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,693	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts Payable
-	-	-	-	-	-	-	-	-	-	-	-	844	936	979	-	763	526	517	-	622	711	624	668	568	548	-	-	-	551	-	-	-	0	0	-
Accounts payable - trade
328	627	609	538	1,035	518	478	571	663	698	209	434	-	-	-	1,087	-	-	-	512	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable - non-trade
-	-	235	235	235	235	235	235	235	235	235	235	383	127	97	97	30	96	375	366	200	212	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Convertible Notes Payable - Related Party
-	-	-	-	-	-	-	-	0	120	407	401	77	88	102	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued Expenses
376	200	200	336	248	884	71	66	7	19	10	229	320	237	229	220	146	169	19	16	49	733	1,005	963	824	858	-	-	-	1,429	-	-	-	-	-	-
Lease liabilities, current
266	261	256	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued expenses and other current liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
Total Current Liabilities
971	1,090	1,301	1,110	1,519	1,638	784	873	906	5,974	951	2,989	1,988	1,405	1,410	1,508	1,043	893	1,014	995	971	1,757	4,933	3,349	3,097	2,134	83	67	71	2,086	47	38	27	22	18	8
Contingent Consideration Liability
-	-	-	-	23,818	23,601	21,423	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
NON-CURRENT LIABILITIES:
Bonds Payable - Related Parties, net of $0, $0 and $502,465 discount
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	997	-	-	-	-	-	-
Derivative Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	850	-	-	-	-	-	-
Total Long Term Liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	309	332	-	-	-	-	0	-	0	0	0	0	0	-	-	-	2,644	-	-	-	-	-	-
Contingent consideration liability
2,006	4,317	5,399	5,667	-	-	-	22,891	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease liabilities, non-current
1,601	1,669	1,737	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Convertible notes payable - long-term
1,200	-	-	-	-	-	-	-	-	-	-	-	258	220	229	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Notes payable - related Party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	0	0	-	-	-	795	-	-	-	-	-	-
Notes payable - long-term, net of discount
4,506	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Total Liabilities
10,286	7,076	8,437	6,777	25,337	25,239	22,207	23,764	906	5,974	951	2,989	1,988	1,715	1,742	1,508	1,043	893	1,014	995	971	1,757	4,933	3,349	3,097	2,134	-	-	-	4,730	-	-	-	-	-	-
COMMITMENTS AND CONTINGENCIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0
STOCKHOLDERS' EQUITY :
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding
-	-	-	-	-	-	0	-	0	0	0	0	0	0	0	0	0	0	0	-	0	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0
Common stock, par value $0.0001, 100,000,000 shares authorized, 46,497,409 shares issued and outstanding at March 31, 2020; 45,273,924 issued and outstanding at June 30, 2019
4	4	4	4	3	3	3	3	3	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Additional paid-in capital
230,364	229,899	229,209	225,765	206,361	206,265	193,369	193,283	176,328	31,629	31,330	29,622	25,816	25,784	25,756	25,098	25,098	25,098	25,098	25,098	25,098	25,098	18,357	17,788	17,788	17,867	24	24	24	12,817	24	24	24	24	24	24
Accumulated deficit
-60,090	-58,575	-56,855	-52,771	-62,596	-57,890	-39,898	-34,755	-32,706	-29,746	-28,669	-28,443	-28,258	-28,012	-27,093	-26,300	-25,545	-25,337	-24,915	-24,565	-23,145	-21,892	-20,938	-20,403	-19,947	-19,521	-	-	-	-17,373	-	-	-	-	-	-
Non-controlled interest in subsidiary
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-
Other comprehensive (loss) income
-55	-45	-176	101	198	338	114	205	-267	-31	97	352	835	942	538	564	382	680	533	543	717	275	199	-16	-27	-31	-	-	-	188	-	-	-	-	-	-
Subscription receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25
Accumulated deficit during the development stage
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	95	79	76	-	56	49	38	34	22	8
Total Stockholders' Equity
170,223	171,282	172,182	173,099	143,968	148,717	153,589	158,737	143,358	1,852	2,759	1,532	-1,606	-1,284	-797	-637	-63	441	717	1,077	2,671	3,482	-2,381	-2,630	-2,347	-1,684	-70	-54	-51	-4,367	-31	-24	-13	-9	2	-8
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
180,509	178,359	180,619	179,877	169,305	173,956	175,797	182,502	144,264	7,827	3,711	4,522	382	430	944	870	980	1,335	1,731	2,072	3,643	5,239	2,551	718	911	450	13	13	19	362	15	13	13	13	20	0